company

Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal

as of 2026-07-01
Monitor thisAsk about this
at a glance
6 trials sponsored · 9 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

9 assets
OlanzapineAvatar therapyBEAM-F3 Intermittent theta burst stimulationCognitive remediation therapy (CR)Neuronavigated Intermittent Theta Burst StimulationSupported education (SE)Transitional Online Peer Support Group (n=20)Treatment-as-usualValidation of questionnaires

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Olanzapine
small molecule
drug
Avatar therapy
BEHAVIORAL
drug
BEAM-F3 Intermittent theta burst stimulation
DEVICE
drug
Cognitive remediation therapy (CR)
BEHAVIORAL
drug
Neuronavigated Intermittent Theta Burst Stimulation
DEVICE
drug
Supported education (SE)
BEHAVIORAL
drug
Transitional Online Peer Support Group (n=20)
BEHAVIORAL
drug
Treatment-as-usual
OTHER
drug